Integrated BioPharma Inc ($INBP) - buy or sell? Stock discussion, ideas, forum

Integrated BioPharma Inc

Integrated Biopharma, Inc.

Industry: Personal Products

Ticker	Exchange	ISIN
$INBP	OTC	US45811V1052

Recent news

Synacor, Inc. reports 33.2% revenue decline in FY2020

BSQUARE Corporation reports 20.5% revenue decline in 2020 and 11.3 pp EBITDA Margin growth from -12.5% to -1.2%

eMagin Corporation CAPEX surged on 125% and Revenue jumped on 10.1%

Viveve Medical, Inc. reports 28.2% CAPEX decline in 2020 and 16.6% Revenue decline

Canadian Solar Inc. Debt jumped on 22.2% and Revenue increased on 8.6%

SMTC Corporation Debt increased on 5.4% while EBITDA decreased on 3.8%

SharpSpring, Inc. revenue growth accelerated from 21.7% in FY2019 to 29.0% in FY2020

Interlink Electronics, Inc. reports 8.1 pp EBITDA Margin growth from -2.3% to 5.9% in 2020 in 2020 while 5.7% Revenue decline

Intellicheck, Inc. Net Income jumped on 122% and Revenue jumped on 40.1%

VirnetX Holding Corp revenue jumped on 355,942% and EBITDA Margin surged on 23,179 pp from -23,127% to 52.2%

Twit about INBP stock

Share your investment idea or question on Integrated BioPharma Inc stock:

Latest twits on Integrated BioPharma Inc (INBP)

No twits yet. Be the first to post!

Have a question about INBP? Ask and other investors will be eager to help you.

Have an idea about INBP? Share it with other investors.

Integrated BioPharma Inc stock price chart

Integrated BioPharma Inc financials

mln. $	FY2016	FY2017	FY2018

Revenue	42.214	46.954	43.710
EBITDA	2.465	3.580	2.042
Net income	0.958	2.346	0.679
CAPEX	0.109	0.327	0.247
Debt	15.520	15.261	9.291
Cash	0.395	0.132	0.228

About Integrated BioPharma Inc

Integrated Biopharma, Inc. develops, manufactures, and distributes biopharmaceutical products worldwide. The Company serves the nutraceutical, biotechnology, and pharmaceutical industries. Integrated provides nutritional supplements and naturally occurring chemotherapeutic anti-cancer agents.